Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27694532 | 0.95 | — | — | |
| Acetic Acid SCHEMBL10386239 | 0.95 | CA1 (0.82) | — | |
| Acetic Acid SCHEMBL28324287 | 0.95 | — | — | |
| Acetic Acid SCHEMBL11411179 | 0.95 | CA1 (0.82) | — | |
| Acetic Acid SCHEMBL22077624 | 0.95 | — | — | |
| Acetic Acid SCHEMBL14691462 | 0.95 | — | — | |
| Acetic Acid SCHEMBL9498718 | 0.95 | — | — | |
| Acetic Acid SCHEMBL449428 | 0.95 | CA1 (0.82) | — | |
| Acetic Acid SCHEMBL1987748 | 0.95 | CA1 (0.82) | — | |
| Acetic Acid SCHEMBL28086877 | 0.95 | CA1 (0.82) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116475425-A | Method for synthesizing gold/silver core-shell structure nano particles | 贵州大学 | 2023-07-25 | — | — | CN | claimed |
| CN-115677817-A | Production process and device for synthesizing polypeptide | 黄山学院 | 2023-02-03 | — | — | CN | claimed |
| CN-112028914-A | A kind of18F-boron trifluoride tyrosine kit and application thereof | 北京大学 | 2020-12-04 | — | — | CN | claimed |
| CN-107304420-B | Method for extracting bovine pancreatic RNA, product and application thereof | 北京大学 | 2020-11-27 | — | — | CN | claimed |
| CN-110194812-A | One boar lung source refining crude heparin sodium method | 四川农业大学 | 2019-09-03 | — | — | CN | claimed |
| CN-107304420-A | Ox pancreas RNA extracting method and products thereof and purposes | 北京大学 | 2017-10-31 | — | — | CN | claimed |
| CN-105520251-B | A kind of preparation method of edible deerskin field exploration clothing | 汪振朴 | 2017-08-01 | — | — | CN | claimed |
| CN-105520251-A | Preparation method for outdoor exploration clothes from edible deerskin | MEI QINGBO | 2016-04-27 | — | — | CN | claimed |
| CN-103690996-A | Biological compound material based on fish skin collagen and preparation method of biological compound material | YANGTZE RIVER FISHERIES RES INST CAFS | 2014-04-02 | — | — | CN | claimed |
| CN-101919811-A | Levetiracetam injection and preparation method thereof | BEIJING BOSHI ANTAI LIQUID PREPARATION TECHNOLOGY CO LTD | 2010-12-22 | — | — | CN | claimed |
| CN-1814293-A | Method for preparing PH-responding medicine release system by virus coating | TIANJIN TECHNOLOGY UNIV (CN) | 2006-08-09 | — | — | CN | claimed |
| EP-3731812-B1 | WATER-DISPERSIBLE TABLET FORMULATIONS COMPRISING DEFERASIROX | SANOVEL ILAC SANAYI VE TICARET AS (TR) | 2025-11-26 | — | — | EP | disclosed |
| CN-119997951-A | Method for preventing, alleviating and/or treating PTGS 2-induced skin disorders and related dysfunctions | 西姆莱斯股份公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119968452-A | Perfume mixture (VI) | 西姆莱斯股份公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119790128-A | Perfume mixture (III) | 西姆莱斯股份公司 | 2025-04-08 | — | — | CN | disclosed |
| EP-0561953-A1 | RECOMBINANT IMMUNOTOXIN COMPOSED OF A SINGLE CHAIN ANTIBODY REACTING WITH THE HUMAN TRANSFERRIN RECEPTOR AND DIPHTHERIA TOXIN | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1993-09-29 | — | — | EP | disclosed |
| US-5248507-A | HYPERTONIC ISOCHLOREMIC FORMULATION FOR CIRCULATORY SHOCK | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-09-28 | — | — | US | disclosed |
| WO-1992021356-A1 | HYPERTONIC ISOCHLOREMIC FORMULATION FOR CIRCULATORY SHOCK | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-12-10 | — | — | WO | disclosed |
| EP-0321094-A2 | Treatment of factor VIII inhibitors | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-06-21 | — | — | EP | disclosed |
| US-4766107-A | 16-Oxa-bicyclo-[13.1.0]-hexadec-7-ene and its application as a fragrance | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1988-08-23 | — | — | US | disclosed |